Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

2010 Expert Reviews Ltd. Cite this: Vaccine Presentation in the USA: Economics of Prefilled Syringes versus Multidose Vials for Influenza Vaccination - Medscape - Nov 01, 2010.

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...

SMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference, to be held in San Diego. As part of SMi’s leading series of drug delivery device conferences, the 2022 ...

If you’re looking for a cannabidiol (CBD) product to soothe your aches and pains, a topical CBD — such as a CBD cream — may be particularly useful. But how can you tell which CBD creams are ...

and e-cigarettes with a prefilled cartridge or pod that is intended for reuse. E-cigarette aerosol can include nicotine, cancer-causing chemicals, heavy metals, volatile organic compounds ...

Insulin pens with ultra-fine needles and pre-filled cartridges ensure minimal discomfort, while insulin pumps offer continuous delivery without frequent injections. With proper training ...

At SMi’s 2019 Pre-Filled Syringes East Coast USA Conference, industry leaders will meet in Boston to share their insights on best design practice, drug compatibility within the whole supplier ...

Roche announced that the European Medicines Agency (EMA) issued approval for faricimab (Vabysmo) in a 6.0 mg single-dose prefilled syringe (PFS). The PFS is approved for 3 indications: neovascular age ...

Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency approved the Vabysmo 6 mg prefilled syringe for three retinal conditions ...